Minerva Neurosciences, Inc. (NERV)

NASDAQ: NERV · IEX Real-Time Price · USD

3.140

-0.080 (-2.48%)

At close: Jul 19, 2024, 4:30 PM

3.010

-0.130 (-4.14%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Minerva Neurosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	0	0	0	0	41.18	0	Upgrade
Gross Profit	0	0	0	0	41.18	0	Upgrade
Selling, General & Admin	10.23	10.41	10.58	13.33	17.29	17.74	Upgrade
Research & Development	14.22	12.71	14.65	32.04	22.04	58.12	Upgrade
Operating Expenses	24.45	23.12	25.23	45.37	39.33	75.87	Upgrade
Operating Income	-24.45	-23.12	-25.23	-45.37	1.85	-75.87	Upgrade
Other Expense / Income	7.15	6.89	6.88	6.34	-0.09	-1.43	Upgrade
Pretax Income	-31.6	-30.01	-32.11	-51.71	1.94	-74.44	Upgrade
Income Tax	0	0	0	-1.8	0	-2.25	Upgrade
Net Income	-31.6	-30.01	-32.11	-49.91	1.94	-72.18	Upgrade
Shares Outstanding (Basic)	8	7	5	5	5	5	Upgrade
Shares Outstanding (Diluted)	8	7	5	5	5	5	Upgrade
Shares Change	41.74%	21.84%	-0.00%	4.41%	4.88%	0.57%	Upgrade
EPS (Basic)	-4.48	-4.61	-6.01	-9.35	0.40	-14.80	Upgrade
EPS (Diluted)	-4.48	-4.61	-6.01	-9.35	0.40	-14.80	Upgrade
Free Cash Flow	-20.76	-14.78	-24.66	-24.6	-33.82	-43.43	Upgrade
Free Cash Flow Per Share	-2.74	-2.27	-4.62	-4.61	-6.63	-8.91	Upgrade
Gross Margin	-	-	-	-	100.00%	-	Upgrade
Operating Margin	-	-	-	-	4.49%	-	Upgrade
Profit Margin	-	-	-	-	4.71%	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-82.14%	-	Upgrade
EBITDA	-31.57	-29.97	-32.1	-51.61	2.12	-74.28	Upgrade
EBITDA Margin	-	-	-	-	5.14%	-	Upgrade
Depreciation & Amortization	0.03	0.03	0.01	0.1	0.18	0.16	Upgrade
EBIT	-31.6	-30.01	-32.11	-51.71	1.94	-74.44	Upgrade
EBIT Margin	-	-	-	-	4.71%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).